Vice President of Revenue Operations
BlueCatFull Time
Expert & Leadership (9+ years)
The VP/GM Clinical role requires experience in building and leading clinical business organizations and core competencies. Candidates must have a proven track record in developing and executing global strategies and operating plans for clinical solutions, including instrumentation, software, analytics, and assays. Experience in managing cross-functional teams, R&D pipelines, and ensuring compliance with regulatory bodies like the FDA and EMA is essential. The role also demands strong leadership skills, talent development, P&L management, and a deep understanding of clinical market dynamics.
The VP/GM Clinical will be responsible for building the clinical business organization and developing its core competencies. Key duties include creating and implementing a multi-year global strategy to expand the clinical business, leading go-to-market plans for existing solutions, and driving an innovative R&D pipeline for total workflow solutions. This includes collaborating with R&D, quality, regulatory, and operations to ensure clinical requirements are met and designing business processes that align with patient and provider experiences. The role also involves leading the organization to deliver a complete portfolio of clinical solutions at scale, ensuring regulatory compliance, and fostering seamless collaboration across global and regional teams. Additionally, the VP/GM will establish a culture of accountability, champion cross-functional collaboration, develop talent, and manage the global P&L to achieve revenue and profit growth.
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.